Index

Pg1 - Introduc!onPg2 - Execu!ve SummaryPg3 - 4 - DemographicsPg4 - Marke!ng SegmentPg5 - 6 - Product Bene"ts - D’CarePg7 - 9 - Products Bene"ts - G’Wellness

Pg17 - 21 - New ProductsPg22 - 25 - Siddha Philosophy

Appendix A - Diabetes country and regional dataAppendix B - Laboratory and technicle resultsAppendix C - FDA Registra!on, TGA Lis!ng, GMP Approval

Appendix D - Technical SupportAppendix E - Process Technology

Pg10 - 16 - Marke!ng Material Pg13 - 15 - 3D Anima!on Pg16 - Packaging Alterna!ves

1

DG Biocare Group Australia Pty Ltd has identified and are exploiting novel technologies that can transition traditional medicine paradigms into modern pharmaceutical products. Siddha medicines paradigms have been examined and some of their most efficacious preparation regimes have now been transitioned into modern manufacturing regimes. DG Biocare’s regime can process herbs using modern pharmaceutical manufacturing techniques that closely mimic ancient regimes, resulting in demonstrably enhanced effectiveness and potency when compared with existing chemical extraction processes.

A GMP licensed pilot plant facility (in part, owned by DG Biocare GroupAustralia Pty Ltd has been established in Malaysia and is operating to provide pre-commercial quantities of 180,000 x 500ml bottles per month of the two flagship products currently listed with the Therapeutics Goods Administration (TGA Australia and FDA America). The products have indications for chronic disease moderation and potentially prevention as well as restoration of health and wellbeing lost due to infection or disease.

Production can be doubled at the current factory location without diminishing the quality or potency of the products

,whilst larger premises are being

established.

Introduc!on

Our Production family has been awarded BioNexis status, which qualifies us for International Financial assistance in the development under the Asian Agreement for Humanitarian Assistance in the region.

Execu!ve Summary D’G Biocare Group Australia Pty Ltd offers a proven scientific solution to most of today’s health problems. The foundation of our research has been built on Siddha Traditional Herbal Medicines that has evolved over 2000 years and is now recognised by today’s medical science as true and tested. Applied new sciences to this Traditional Medicine has produced a new era in Complimentary Medicine that provides the catalyst for our body to protect and generate the growth of new healthy cells.

D’G Biocare Group Australia Pty Ltd have a strong and dedicated team supported by local and internationally acclaimed professionals that have pledged their ongoing involvement in the scientific, medical and promotional development of the business.

Our products are distribute through Pharmacies and Health Food Stores as well as on line sales via our web site www.dgbiocaregroup.com

D’G Biocare Group Australia Pty Ltd, with our research partners, are introducing the first two products to the market. Each product has its own designed formulation,prepared using the same Siddha principals and applied sciences, that yield very high concentrations of anti oxidants and polyphenols

D’G Biocare Group Australia Pty Ltd is the International marketer of the products and a major shareholder in the manufacturer / intellectual property / patents pending (process and machinery).

Products: “D’Care is saving diabetics from the pain and suffering of diabetes. Testimonials by D’Care users have excitedly reported sugar levels reduced to manageable and normal within days, by just taking 20 to 30 ml of D’Care daily. Added benefits have been: increased energy & concentration; improved blood circulation; repaired damaged organs including eyesight; and healed wounds. The overall theme of the statements received have been, “Thank you D’Care.

G’Wellness has been designed for general wellness and has been credited by testimonials and supported by University Testing for the treatment of liver disorder, Rheumatism, Chronic Fatigue Syndrome, Crohn’s Disease, poor blood circulation, high cholesterol and Dengue Fever Virus.

Athletes have praised G’Wellness for their improvement in recovery time, increased concentration, elimination of cramping and their ability to improve on pastperformances by breaking down the muscles retention of lactic acids.

The objective of this Business Plan is to convey to the readers that we have theproducts and knowledge of our products, as well as the management skills to ensure the success of the business.

D’G Biocare Group Australia Pty Ltd patentable sciences have developed a full range of complimentary medicines based on the Siddha Traditional format. Our new range of products will be released in conjunction with our marketing strategy and the capacity to meet market demands.

PTmAco

GteRh

2

diseases also cause major limitations in daily living for almost 1 out of 10 Americans or about 25 million people

Within Asia/Pacific

.

Aging and the rise of chronic diseases such as heart attack, stroke, diabetes, respiratory diseases and cancer do not have just major health and social implications, but also economic and financial costs. Chronic diseases could result in some national income losses of $550 billion in China and $225 billion in India between 2005 and 2015!Within Europe

.

A relatively small group of health conditions is responsible for a large part of the disease burden in Europe. Of the six WHO regions, the European Region is the most affected by non-communicable diseases (NCD), and their growth is startling. Cardiovascular diseases (CVD) are the number-one killer, causingmore than half of all deaths across the Region"Major Ac!vi!es

.

To date, DG Biocare Group Australia Pty Ltd has focused its energies on defining and translating ideas into tangibles, successfully transiting two medicinal products from concept through to commercially available products. It currently has plans for a range of companion and analogous products to bedeveloped in a similar manner. DG Biocare Group Australia Pty Ltd is also funding research and clinical assessment into its flagship products to facilitate their long-term acceptance in the professional medical environment. Near future activity will focus on a balance between commercial growth and ongoing research.

Demographics

Within Australia

IHW analysis of the 2004-05 National Health Survey showed that just over 7 million people have at least one chronic condition, and the proportions having a condition increase with age, as do the proportions of people reporting more than one chronic condition2

Within USA

.

Chronic diseases—such as heart disease, cancer, and diabetes—are the leading causes of death and disability in the United States. Chronic diseases account for 70% of all deaths in the U.S., which is 1.7 million each year. These ########################################################

3

4

Market Segment

DG Biocare Group Australia Pty Ltd has positioned itself uniquely within arapidly growing market segment. DG Biocare Group Australia Pty Ltd products are oral liquids as opposed to the majority of complementary medicines that are provided in capsule or tablet form. The oral liquids market sector appears to be both the most rapidly expanding and have the highest on-shelf price point, as evidenced by newly emerging trend product such as Olive Leaf Extract. It can be noted that complementary medicines have grown significantly in the last 12 months and were relatively unaffected by the GFC.

D’Care Market Segment#Australia has a registered diabetic population of approximately 2 million people with a growth factor of 274 registered diabetics daily as reported by The Diabetic Association of Australia. DG Biocare Australia Pty Ltd will target 5% of the market within the first 2 years, which will result in sales of 100,000 bottles of D’Care per month.

World statistics range from 280 million – 400 million diabetics. If we work on 300 million and capture 0.2% of the available market, this would represent 600,000 bottles per month with an annual growth of 6%.D’Care11 is a potent natural medicine that has been designed for individuals who have an imbalanced metabolic/digestive function. For example:

! It supports normal glycemic control (healthy blood sugar)! Helps maintain normal cholesterol balance! Maintains ideal blood pressure! Promotes cardiac wellbeing! Assists with appetite, weight & stress management

Major Assets

! World Wide distribution rights! Malaysian Government & TGA Licensed Manufacturing facility (in Malaysia)

– GMP Client ID 53768! Pending Patent for novel liquid extraction device ! Patent pending for novel product manufacturing technology! TGA Listing for D’Care – AUST L 176600! TGA listing for G’Wellness – AUST L 176135

! New products under development! Xcell Energy Drink - Ready for release

! FDA (United States of America) Registered

What’s In D’Care

5

D’Care

WITHANIA CINNAMON TURMERIC BITTER MELON GYMNEMA ANDROGRAPHIS FENUGREEK

BLOOD SUGARIMBALANCE

BLOOD PRESSURE

WEIGHT CONTROL

LIVER

DETOXIFICATION

DIGESTIVE

ENERGY

CHOLESTEROL

STRESS

CARDIO

GLANDULAR

LIPIDS

What are the bene"ts to your body from the herbs used in D'Care

D’Care

D’Care is a potent, naturally derived medicine specifically designed for ‘Successful aging’ & individuals who have an imbalanced metabolic/digestiveFunction.

Examples of some of the benefits include:

! Supports normal glycemic contro (healthy blood sugar)! Helps maintain normal cholesterol balance! Maintains ideal blood pressure! Promotes cardiac wellbeing! Assist with appetite, weight and stress management

6

7# #

# ##Whats in G’Wellness

Please refer to ‘Appendix B’ for Technicle and Laboratory results

G’Wellness

WITHANIA CINNAMON TURMERIC SAFFRON CENTELLA GARLIC ONIONLIVER

ENERGY

STRESS

CARDIO

INFECTION

BLOOD PRESSURE

CHOLESTEROL

ARTHRITIS

DETOX

MILD ANXIETY

IMMUNE

DIGESTIVE

COLD & FLU

LIPIDS

What are the bene"ts to your body from the herbs used in G'Wellness

##################

G’Wellness is a potent, naturally derived medicine specifically designed for individuals who suffer from or are experiencing difficulty in recovering from prolonged or debilitating illness. For example :

! Fatty Liver! Chronic Fatigue Syndrome (CFS)! Rheumatoid Arthritis (RA)

G’Wellness helps to balance and resolve physical and emotional stresses, promotes circulation and enlivens and re-energizes the body and mind.

G’Wellness is also specified for :

! Treatment of mild digestive disorders! Treatment of cold & flu! Maintenance of cardiac & circulatory health! Moderating age related vascular changes! Maintaining healthy cholesterol levels! Supporting the immune system! Stimulating and protecting the growth of healthy cells

8

G’Wellness

9

! For daily wellbeing maintenance, 10 ml after breakfast! For athletes 20 - 40ml daily.

! For the treatment of cold & flu, up to 20 ml twice daily! For CFS, RA etc, 50 – 60 ml over 3 doses daily! Select the desired dose & dilute in warm water! It is a pleasant taste & no flavouring is added

Over 60 actives in G’Wellness One component at 200, 60+ components at MORE than 25 above 100

G’Wellness

Marke!ng &Promo!on

10

1,2,3 & 4 BottlePostage Packages

Counter Display Stand

D’Care & G’Wellness Radio Pedometers

Floor Display Stand

066 www.oceanroadmagazine.com.au

ADVERTISEMENT

The rigours of elite golf can take their toll on a player, as Sanctuary Cove touring professional Brad Kennedy knows only too well. The treadmill of constant tournaments, living out of a suitcase and dealing with jetlag can sap the energy levels of even the fittest of sportsmen.Brad has been dealing with all of that for the 14 years he has been a professional golfer, but two years ago he found an answer to the fatigue. He started taking the natural herbal tonic G’Wellness and says he has never felt better.“It has lifted my energy levels in general but it has also helped with my recovery from training,” Brad says. “I follow a much more physically demanding

BRAD BACK IN THE swing

D’Care G’Wellness

training program than I used to and I find I can do a session in the afternoon and still feel fresh to play golf the next morning.”

G’Wellness, manufactured by D’G Biocare Group, is a preservative-free, natural wellness tonic made according to the ancient principles of Siddha Medicine.

Brad binned all the multivitamins and other supplements he used to take and now relies solely on G’Wellness to keep him physically and mentally alert.

Brad’s improved sense of wellbeing is also paying dividends on the course. Last November he won his first Australian PGA title, the WA Open, and in June

IF YOU WANT THE EDGE TO WIN THEN TAKE G’WELLNESS

this year posted a top-three finish in the lucrative Japan Golf Tour Championship Citibank Cup. “That’s down to a combination of things,” Brad says of his run of good form, “but G’Wellness has certainly helped. Golf is a tough game and I’m not getting any younger so it has helped me get physically where I need to be.”Available at selected healthfood and chemist stores.

D’G BIOCARE GROUP OFFICEShop G9c, 47 Ashmore Road, Bundall Phone 07 5699 9910 or 1800 220 061Email: info@dgbiocaregroup.comwww.dgbiocaregroup.com

11

D’Care Poster

G’Wellness Poster

12

13

3D Anima!on

D’G Biocare Workers & Blood Corpuscles, sick and healthy

14

Sick Blood Corpuscles

Healthy Blood Corpuscles

15

Danny D’Care

Gerry G’Wellness

16

17

New Productsready for release

--Gout

Prostate- Rheuma!sm

- Xcell Sports Energy Drinks

18

XCELL ENERGY DRINK herbs and benefits1. Withania somnifera – (Aswaganda)

-Aswagandha as Immunity Booster-As Body building Aid. -Refresh energy and the rejuvenating effect.

Percentage of Herbs in 250ml packing is 50mg

2. Terminalia Chebula – (Black Myrobalan)

-It promotes the receiving power of the five senses. ... That is capable of activating the senses from within the brain... of perception.

Percentage of Herbs in 250ml packing is 50mg

3. Alium Satium – (Garlic)

-To boost the immune system-It strengthens the body's natural defenses and maintains healthy cardiovascular function.

Percentage of Herbs in 250ml packing is 50mg

4. Cynodon dactylon – (Durva grass)

- strengthens the immune system and improves blood flow to the veins.

Percentage of Herbs in 250ml packing is 50mg

5. Cinnamomum Zeylanicum – (Cinnamon)

- strengthens the immune system to keep your body healthy and strong.

Percentage of Herbs in 250ml packing is 50mg

6. Honey

-Honey is nature’s energy booster -Honey is a great immunity system builder -Honey is a natural remedy for some ailments

Percentage of Honey in 250ml packing is 50ml

19

20

21

22

DG BIOCARE GROUP AUSTRALIA

PROPRIETARY USING THE SIDDHA (Agasthiyar Agastya) PRINCIPAL OF ANCIENT PHILOSOPHY OF MEDICINE FROM ONE OF

THE 18 SIDDHAS’

MANUFACTURED USING STATE OF THE ART BIOTECHNOLOGY

www.dgbiocaregroup.com

23

! The Human immune system has the ability to protect your body from the environment that contains bacteria, virus, toxin and pollutants that constantly assault us.

! This is true only when you are alive and living. Your body begins to decay and decomposes because of the bacteria, virus and pollutant present in our atmosphere.

! Our endocrine system together with the immune system has the ability to heal and cure any illness. Your body is the most quali!ed doctor and physician in the universe.

! The endocrine system releases many hormones that regulate our biological func"ons and keeps us away from illness. For example if you were struck down with in#uenza, an illness which is caused by virus, the body as the ability to self heal.

! But Given su$cient "me and rest the body may heal the illness. This is also true in the case of any cut or bruises that you may have su%ered. Our body has the ability to heal itself.

Principals of Biotechnology

24

! Cells, "ssues and organs within the body and serve as the organism’s main communica"on network and as the principal regula"ng instance for ALL life processes. The processes of morphogenesis, growth, di%eren"a"on and regenera"on are also explained by the structuring and regula"ng ac"vity of the coherent Biophoton !eld.

! The holographic Biophoton !eld of the brain and the nervous system, and maybe even that of the WHOLE organism, may also be basis of memory and other phenomena of consciousness, as postulated by neurophysiologist Karl Pribram and others. The consciousness-like coherence proper"es of the Biophoton !eld are closely related to its base in the proper"es of the physical vacuum and indicate its possible role as an interface to the non-physical realms of mind, psyche and consciousness.

! The discovery of Biophoton emission also lends scien"!c support to some unconven"onal methods of healing based on concepts of homeostasis (self-regula"on of the organism), such as various soma"c therapies, homeopathy and acupuncture.

! The “chi” energy #owing in our body’s energy channels (meridians), which according to tradi"on Chinese medicine regulates our body func"ons may be related to node lines of the organisms Biophoton !eld. The “prana” of Indian yoga physiology may be a similar regula"ng energy force, that has a basis in WEAK, coherent electromagnetic Biophoton !elds.

Biophoton Field

25

! Herbs have mul"ple e%ects on our body. Herbs work by supplying the body with many di%erent nutrients that tone and revitalize. Because of their diverse chemical forma"on, they are e%ec"ve in small doses and produce few side e%ects.

! Some herbs work as general tonics that cleanse, nourish and rebuild on a

!

cellular level. Others have an a$nity for a speci!c system or organ, and may be used to treat related imbalances or symptoms. They work gently and naturally to support the body’s own healing process.

Herbal Bene"ts

When mul"ple herbs are balanced and formulated to our process.The bene!ts of a single tonic containing these herbs will enhance the overall health bene!ts of these herbs

! D’G Biocare’s process of extrac"on retains the living and ac"ve molecules that are natural to the herbs.These ac"ve ingredients are maintained in our tonics.

! Herbs are natural to our bodies and when taken as presecribed, will work with our bodies in the healing process and maintenance of good health, with no adverse side e%ects.

Diabetes - Global Country and regional data

WHO Eastern Mediterranean Region

Prevalence of diabetes in the WHO Eastern Mediterranean Region

2000 2012

Total 15,188,000 28,894,000

WHO European Region

Prevalence of diabetes in the WHO European Region

2000 2012

Total 33,332,000 40,652,500

WHO Region of the Americas

Prevalence of diabetes in the WHO Region of the Americas

2000 2012

Total 33,016,000 49,914,000

WHO Western Pacific Region

Prevalence of diabetes in the WHO Western Pacific Region

2000 2012

Total 35,771,000 53,410,550

WHO South-East Asia Region

Prevalence of diabetes in the WHO South-East Asia Region

2000 2012

Total 46,903,000 83,234,168

World

Prevalence of diabetes worldwide

2000 2012

World 171,000,000 268,500,000

Note: The figures above where projected from the year 2000, since then WHO have revised their estimations upwards to nearly double, as indicated in recent reports from China, India and America.

NEW DIABETES FIGURES IN CHINA: IDF PRESS STATEMENTSubmitted by admin on Wed, 03/24/2010 - 15:51

Professor Jean Claude Mbanya, President, International Diabetes Federation, comments

on the findings and implications of a new study in China published by the New England

Journal of Medicine.

China now the country with the largest number of people with diabetes

Previous estimates in the International Diabetes Federation’s (IDF) Diabetes Atlas Fourth

Edition - published in October 2009 - put the number of people with diabetes in China at

43.2 million, based on the best evidence available at the time.

Now, it would appear China has overtaken India and become the global epicentre of the

diabetes epidemic with 92.4 million adults with the disease.

Some of the difference between the old and new estimates for China may be due to

differences in methodology. However, the new figures certainly reflect a rapid increase in

the prevalence of diabetes over recent years.

Due to the new study, we expect the projected estimates of the number of people with

diabetes in the year 2030 will be close to half a billion.

Why the large disparity between the old and new estimates; implications for policy maker

It is not entirely surprising that the new study estimates there are nearly twice as many

people in China with diabetes than previously thought. IDF based its 2009 figures for

China on the findings of a study by Gu et al in 2003 - the best data available at the time.

It is important to note that IDF uses a conservative modelling approach. When new

studies are conducted around the world, we see a leap in diabetes figures.

We welcome the findings of this new study published in the New England Journal of

Medicine. The methodology is good as it uses a large, well-constructed sample and the

gold standard method for detecting diabetes, the Oral Glucose Tolerance Test, as

recommended by the World Health Organization.

This shows that the global burden of diabetes is far larger than previously estimated. It

is a wake-up call for governments and policy-makers to take action on diabetes - a

major public health problem.

Level of public awareness of diabetes in China

Around the world, there are many people with diabetes who remain undiagnosed. In

some poorer countries, 80% to 90% of people with diabetes are undiagnosed; while

even in high-income countries 30% may be undiagnosed.

In China, 60.7% are undiagnosed, and this is likely to result from the combination of

poor public awareness and limited opportunities for diagnosis.

People often have type 2 diabetes for a long time before it is diagnosed. For many

people, the diagnosis comes when they make contact with the health system for other

reasons (for example when admitted to hospital with a heart attack). The longer people

are undiagnosed, the more likely it is that their blood glucose will be poorly controlled

and therefore their risk of developing diabetes complications, that can affect their sight,

kidneys or lead to amputations or stroke, will be higher.

In China, there is room to increase the proportion of people who are diagnosed, but this

needs to be backed up with sufficient resources to manage and treat larger numbers of

people with diabetes. Diagnosing more cases without being able to increase the amount

of care available will do little to improve the lives of people with diabetes.

How China's health system is equipped to handle diabetes; challenges and importance of education, primary healthcare reform

Through our interactions with Chinese medical authorities, we know that China is

committed to primary healthcare reform (ie. dealing with diabetes and other diseases at

the grassroots level such as clinics, general practitioners etc.) and interdisciplinary

education and care (ie. healthcare delivered to people with diabetes by a team of

professionals from different disciplines, eg. education, nutrition, endocrinology etc.).

There are excellent interdisciplinary programmes being provided in some parts of China

such as Beijing and Shanghai. However, the sheer number of people with diabetes

presents a great challenge.

A landmark study in China in 1997 proved that prevention works. The Da Qing study

showed that increasing physical activity and improving diet reduces the incidence of type

2 diabetes. Recently, a follow-up study has shown that the effects continued to last after

20 years.

The challenge now for China - and all countries – is to find ways to help people to be

more physically active and improve their diets. This requires an integrated approach,

and involves other sectors outside of health, for example those that influence urban

design and food legislation.

IDF’s member association in China, the Chinese Diabetes Society, is working with

Chinese health officials to promote education and self-management of the condition,

which is vital in dealing with diabetes.

How lifestyle diseases are overtaking infectious diseases in developing countries; economic impacts; steps to redress the situation

In countries such as China and India, which are showing rapid economic development,

we are seeing mass urbanisation, changing diets and increasingly sedentary lifestyles.

These factors greatly increase one’s risk of developing type 2 diabetes.

Evidence shows that the burden of diabetes continues to shift to low and middle-income

countries, making it very much a development issue. The World Health Organization

predicts India and China will respectively lose US$236.6 billion and US$557.7 billion of

national income to diabetes and cardiovascular disease between 2005 and 2015.

According to IDF estimates, the latest prevalence figures emerging from China will mean

healthcare expenditure on diabetes in the country this year will increase by at least

US$1.9 billion, reaching a total of US$ 6.9 billion.

Policy-makers need to integrate plans for the prevention of diabetes into national health

systems. Countries have to find ways to develop economically in a way that is not

harmful to health. This requires creative thinking and legislation that helps people to be

physically active and eat appropriately. People need to be supported and encouraged to

make healthy choices, and the environment needs to be developed in a way that

supports this.

Profile

EMBARGOED: WED, August 26, 2009

Dr Gary Deed MBBS FACNEM Dp Herb Med

Dr Gary Deed is the immediate past President of Diabetes Australia, having held the position from November 2006 until August 2009.

Dr Deed has a particular interest and passion in advocating and lobbying for better health outcomes for and on behalf of people with diabetes in Australia.

Dr Deed is a general practitioner is living with type 1 diabetes and is committed to his role as an advocate for people with diabetes starting from 995 when he joined the diabetes Australia Queensland Board. He has been further involved in National Advocacy with close liaison and support for the Parliamentary Diabetes Support group, and on Commonwealth committees addressing public Health initiatives in chronic disease and diabetes.

Dr Deed is also the Chair of the Health Research Ethics Committee and Academic Board member of the Australian College of Natural Medicine and President of the Australasian College of Nutritional and Environmental Medicine. He is a member of the Complementary Medicines Evaluation Committee of the Therapeutic Goods Administration. He is a Patron of MINDD which is a not for profit in support of children with Autism and Behavioural disorders.

ends#

To coordinate an interview with Dr Deed, please contact Kirsten Bruce or Michaela Patton from VIVA! Communications on 02 9884 9011 or m 0401 717 566 / 0423 877 748.

USQ scientists awarded grants for vital health research in Queensland and IndiaUSQ scientists expect to improve the treatment of heart disease, diabetes and obesity in both Queensland and India after being awarded more than $535,000 in funding this month (October).

USQ academics Professor Lindsay Brown, Professor Raj Gururajan, Dr Abdul Hafeez-Baig and Dr Heng-Sheng Tsai will partner with Professor MK Unnikrishnan from Manipal University in India and industry partners in both Queensland and India to assess potential new treatments.

The grant has been provided under a joint initiative of the Queensland and Indian Governments, the Indo-Queensland Biotechnology Fund, with $160,000 from the Department of Employment, Economic Development and Innovation (Queensland) and the Department of Biotechnology (India), as well as a further $50,000 from USQ.

The industry partners will further provide more than $200,000 in financial assistance for this three-year project.

This collaboration will offer a multi-pronged attack on obesity by studies in two areas of medical biotechnology: drug design/development and information technology.

'My research group will use novel compounds developed by Professor Unnikrishnan to activate energy use by cells in the body,' Professor Brown said.

'We will also work with Professor Gururajan and his colleagues to apply cutting-edge information technology to measure changes continuously in diet-induced obese rats.

'Professor Gururajan’s aim is then to further develop this technology with the help of industry partners to provide better collection of relevant information in overweight and diabetic patients for medical practitioners.'

Professor Gururajan said the research was in line with their prior work in developing solutions for health services and addressing emerging health issues.

Dr Hafeez-Baig and fellow USQ researcher Dr Sharad Rajendaran were also awarded two State Government Early Career Fellowships of $32,500 and $38,000 respectively to further their work in Indian institutions.

Dr Hafeez-Baig will spend 12 weeks early next year at the PSG Super Speciality Hospital in Coimbatore to fine-tune a method to monitor cardiac patients remotely.

Dr Rajendran will spend 16 weeks at Manipal University to synthesise and purify new compounds to be tested at USQ with Vijay Mor, a PhD student jointly supervised by Professor Unnikrishnan and Professor Brown.

This is the first time USQ has been awarded these fellowships.

USQ Vice-Chancellor and President, Professor Bill Lovegrove, congratulated the scientists on this very significant achievement.

'This funding adds a strong research dimension to the University’s developing links with India and is a great example of USQ’s developing capacity in multidisciplinary research,' Professor Lovegrove said.

USQ Professor Lindsay Brown willlead a research team to assess

potential new health treatments inQueensland and India

1 of 4

talktous@qualitymatterssafetymatters.com.au Po Box 7028, Loganholme, 4129Phone 0439 782 869 ABN: 99 121 846 053

Curricula vitae

Mrs Wendy Free B.Sc M.Tech Mngt MASM MASCC MATGC MWIT FAOQ

Results Oriented, Pharmaceutical Industry Professional;specialising in the seamless transition of concept into desirable, tangible outcomes

Director:Quality Matters Safety Matters Pty Ltd

ABN 99 121 846 053PO Box 7028, Loganholme 4129

Fax 07 3806 1297Phone 0439 782 869

. Passions! Picking Winners - Identifying and developing novel and innovative concepts into genuine,

quality products and services! Dream Fruition – Knowledge that products are a ‘perfect fit’ for their intended market! Professionalism - Timely Provision of Appropriate, Usable Expertise

D’G Biocare - Biophotonics Technology